Introduction
Holoprosencephaly (HPE) is the most common structural anomaly of human brain development, with a prevalence of w1 in 250 conceptuses and w1 in 16,000 at birth (Muenke and Beachy, 2001; Yamada et al., 2004) . The most severe form (alobar HPE) is characterized by a complete failure to form an interhemispheric fissure in the prosencephalon, resulting in a single brain ventricle. Progressively less severe forms (semilobar and lobar HPE, respectively) are characterized by graded degrees of forebrain cleavage, but the range of midline defects extends from most to least severe in an uninterrupted continuum referred to as the HPE spectrum Muenke and Beachy, 2001) . Associated craniofacial anomalies extend from cyclopia with overlying proboscis through HPE ''microsigns'' such as solitary median maxillary central incisor. Mutations in eight different genes have been identified in human HPE, but these account for only w20% of the total cases examined . Prominent among HPE genes are several that encode components of the Sonic Hedgehog (SHH) pathway, including SHH itself, PTCH1, and GLI2 Nanni et al., 1999; Roessler et al., 2003) . Strikingly, phenotypic heterogeneity is observed even in familial forms of HPE, in which it is estimated that among obligate mutation carriers, 37% will have HPE, 27% will display microsigns of HPE, and 36% will have no clinical manifestation (Cohen, 1989; . Potential explanations for this variability include (1) genetic influences, such as haploinsufficiency for a second HPE gene or other more common genetic polymorphisms, and (2) environmental insults at specific times during fetal development (Cohen and Shiota, 2002; Cordero et al., 2004; Nanni et al., 1999) .
Hedgehog (Hh) family proteins activate an evolutionarily conserved signal transduction pathway (Lum and Beachy, 2004) . The transmembrane protein Patched1 (Ptch1) functions to inhibit the activity of a second transmembrane protein, Smoothened (Smo) ; binding of Hh proteins to Ptch1 relieves this inhibition, stimulating a signaling pathway that culminates in induction of target genes via the Ci/Gli family of transcription factors. Shh signaling regulates growth, patterning, and morphogenesis of a wide variety of body structures, including the limbs, axial skeleton, central nervous system, face, and others (McMahon et al., 2003) . Mice lacking Shh display profound defects in development of these structures and have severe HPE (Chiang et al., 1996) . A conundrum of human HPE is that, even in severely affected patients, including those with mutations in SHH pathway genes, the limbs and internal organs are rarely affected (Muenke and Beachy, 2001) . While several mouse models of HPE exist (Cohen and Shiota, 2002) , none display both the unexplained features of human HPE described above, i.e, the wide spectrum of phenotypes and the lack of involvement of other Shh-dependent structures.
Cdo (also known as Cdon) is a member of the Ig superfamily that positively regulates skeletal muscle development as a component of cell surface complexes that contain several transmembrane receptors and cell-cell adhesion molecules, including the closely related protein, Boc; the Ig superfamily receptor, neogenin, and its ligand, netrin-3; and N-and M-cadherin Kang et al., 1998 Kang et al., , 2002 Kang et al., , 2003 Kang et al., , 2004 . Unexpectedly, mice lacking Cdo on a mixed genetic background display facial defects associated with microforms of HPE (Cole and Krauss, 2003) . We report here that Cdo 2/2 mice on a C57Bl/6 background display a severe form of HPE but without defects in limb development, thus mimicking human HPE and implicating modifier genes as a likely cause of the variable penetrance and expressivity of this malady. Additionally, Cdo 2/2 mice have reduced Shh target gene expression, and Cdo positively regulates Shh signaling in vitro, linking Cdo to the most frequently disrupted pathway in human HPE. Finally, the structural requirements for Cdo's ability to regulate Shh signaling activity are distinct from those required for its role in promoting myogenesis, suggesting that Cdo has multiple, independent functions.
Results
Severe HPE and Reduced Shh Target Gene Expression in C57BL/6 Cdo 2/2 Mice Mice homozygous for a targeted mutation of Cdo on a mixed 129/Sv 3 C57BL/6 background display craniofacial microsigns of HPE with w95% penetrance; this is associated with w35% perinatal lethality (Cole and Krauss, 2003) . On a 129/Sv background, mice lacking Cdo also showed microsigns of HPE, but the penetrance was reduced to w50% and no perinatal lethality was observed (unpublished data). Congenic Cdo +/2 C57BL/6 mice were derived by backcrossing; intercrosses of such animals revealed >80% perinatal lethality among Cdo 2/2 offspring, which had severe forms of HPE. Analysis of newborn mice and embryos typically revealed cebocephalic faces (characterized by a single centrally located nostril, ocular hypotelorism [close-set eyes], and midface hypoplasia) , incomplete cleavage of the forebrain resulting in a single ventricle ( Figures 1D-1J ), and absence of, or rudimentary, olfactory bulbs ( Figure 1H ). Interestingly, developmental patterning of the limbs and axial skeleton was normal in these animals ( Figures 1A, 1C , and data not shown), similar to human HPE where such anomalies are rare (Muenke and Beachy, 2001) .
The prechordal plate (PCP) mesendoderm functions as a source of signals, including Shh, required for induction of ventral forebrain structures and subsequent patterning of the midline of the forebrain and midface; experimental removal of the PCP from vertebrate embryos results in severe HPE (for review, see Muenke and Beachy, 2001; Rubenstein and Beachy, 1998) . Shh produced by the PCP induces expression of genes, including Shh itself, in the developing ventral forebrain (Cordero et al., 2004; Rubenstein and Beachy, 1998) . Cdo expression is repressed by Shh signaling and is therefore dorsally restricted in the developing CNS, including the forebrain (Mulieri et al., 2000; Tenzen et al., 2006 [in this issue of Developmental Cell]). However, Cdo is expressed transiently in ventral mesodermal structures that produce Shh (Tenzen et al., 2006) , including the PCP at E8.5 ( Figure 2A ).
If the reason Cdo 2/2 embryos display HPE is that Cdo functions in the PCP to modulate Shh expression or signaling, it would be predicted that expression of Shh and/or pathway target genes would be reduced in the developing ventral forebrain. mRNA in situ hybridization analysis indicated that Shh expression at E8.75 was similar in the PCP and notochord of Cdo +/+ and Cdo 2/2 embryos, but was reduced in the developing ventral forebrain at this stage and at E9.5 ( Figures 2B and 2C ). Although we cannot exclude subtle differences in the timing or extent of Shh expression in the PCP of Cdo 2/2 embryos, these data suggest that loss of Cdo may result in disruption of Shh signaling in or from the PCP, with a consequent reduction of Shh expression at secondary sites. Consistent with this model, expression of the direct Shh target genes, Gli1 and Ptch1, and the Shh-dependent ventral forebrain marker, Nkx2.1 (Pabst et al., 2000) , was reduced in the developing ventral forebrain of Cdo 2/2 embryos, relative to controls (Figures 2D-2F). Additionally, expression of Fgf8 in the prosencephalon, maintenance of which is dependent on Shh signal-ing (Ohkubo et al., 2002) , was reduced in E9.0 Cdo 2/2 embryos, whereas it was unaffected at the midbrainhindbrain boundary ( Figure 2G ). These results suggest that Cdo functions to regulate Shh signaling specifically during patterning of the ventral anterior midline and provide an explanation for the HPE seen in Cdo 2/2 mice.
Cdo Positively Regulates Shh Signaling In Vitro
Studies in cultured Drosophila cells suggested that a putative fruit fly Cdo ortholog is involved in Hh signal transduction (Lum et al., 2003) . To assess whether Cdo might function to regulate Shh signaling, mammalian cell culture assays with a Gli-dependent luciferase reporter were performed. 10T1/2 mouse embryo fibroblasts were transiently transfected with the reporter construct and treated with a soluble, active form of Shh, ShhN. ShhN strongly stimulated luciferase activity, and the response was completely blocked by the Smo inhibitor, cyclopamine ( Figure 3A ). Cotransfection of an expression vector containing a rat Cdo cDNA enhanced ShhNdependent reporter activity 2.0-to 2.5-fold in a fully cyclopamine-sensitive manner, but had no effect in the absence of ShhN ( Figure 3A) . Efficient induction of Gli-dependent reporter activity by Shh or constitutively active Smo requires high cell density (Taipale et al., 2000) . 10T1/2 cells express low levels of Cdo endogenously Kang et al., 2004) ; interestingly, the amount of Cdo protein produced by these cells increased proportionally with increasing cell density ( Figure 3B ). To assess the role of endogenous Cdo in regulating Shh signaling in 10T1/2 cells, an RNAi approach was pursued. Cotransfection of a mouse Cdo RNAi vector dose-dependently inhibited ShhN-mediated reporter activity, and transfectants showed a significant reduction of endogenous Cdo protein relative to control cells ( Figures 3C and 3D ). Four independent RNAi sequences targeted against Cdo that reduced Cdo protein levels also inhibited reporter activity, while one that did not reduce Cdo levels had no effect on reporter activity (data not shown). Furthermore, cotransfection of the rat Cdo expression vector, which is not fully conserved at the sequence used to knockdown endogenous mouse Cdo and is impervious to the effects of the RNAi vector (data not shown), rescued the ability of ShhN to activate the reporter ( Figure 3E ). In contrast, RNAi to Cdo did not reduce the ability of activated H-Ras to stimulate an AP-1 (TRE)-dependent reporter ( Figure 3F ). Importantly, overexpression of Cdo enhanced, and RNAi to Cdo reduced, induction of the endogenous Gli1 and Ptch1 genes in response to ShhN ( Figure 3G ). Similar results were seen with NIH3T3 cells ( Figure S1 in the Supplemental Data available with this article online). It is concluded that Cdo positively regulates Shh-initiated signaling to stimulate Glidependent transcription and that Cdo may contribute to the density dependence of pathway activity observed in reporter assays in vitro.
One way Cdo enhances Shh signaling is through direct binding to Shh, perhaps as an accessory receptor for Ptch1 (Tenzen et al., 2006 (Taipale et al., 2000; Xie et al., 1998) or by Gli1 itself by w2-fold ( Figures 4A and 4B) , similar to Cdo's effect on ShhN ( Figure 3A ). Furthermore, two independent Cdo RNAi constructs inhibited SmoA1-and Gli1-dependent reporter activity ( Figures 4C and 4D, and Figure S1 , which shows that Cdo RNAi also reduced the response of NIH3T3 cells to Gli1). RNAi-mediated knockdown of Cdo did not alter Gli1 protein levels ( Figure 4E) .
These data suggest that, in addition to binding Shh, Cdo provides a function at a downstream point of the pathway, at the level of Gli transcription factors or regulators of such factors. To explore this in more detail, we analyzed additional Gli constructs. Gli2 is a primary mediator of Shh signaling and contains a repression domain in its amino-terminal region and a bipartite activation domain in its carboxy-terminal region (Sasaki et al., 1999) . As seen with Gli1, RNAi to Cdo blocked Gli2mediated reporter activity without altering Gli2 protein levels ( Figures 4E and 4F) . A Gli2 construct lacking the amino-terminal repression domain (Gli2-DN2) has 4-to 5-fold higher activity than full-length Gli2 (Sasaki et al. [1999] and Figure 4F ) and its activity was also strongly inhibited by Cdo RNAi (Figure 4F ). The Gli2 carboxyterminal activation domain has been defined with GAL4 DNA binding domain fusions and a reporter controlled by the GAL4 binding site (Sasaki et al., 1999) . Chimeras containing the complete carboxyterminal region (designated BD-C) or two individually active parts (BD-A1 and BD-A2) all showed similar activity on this reporter but, unlike full-length Gli2, were unaffected by the coexpression of a Cdo RNAi construct ( Figure 4G ). These results suggest that the need for Cdo in Gli2-dependent reporter activity is explained neither by relief of its repression function nor stimulation of its trans-activation function. We have not observed obvious effects of Cdo overexpression or RNAi on the subcellular localization of transfected Gli1 or Gli2 (data not shown). Consistent with this, Gli1 containing the nuclear localization sequence from SV40 large T antigen (NF-Gli1), as well as this construct harboring the highly active VP16 trans-activation domain in place of the Gli1 trans-activation domain (NF-Gli1/VP16) (Kimura et al., 2005) , retained a significant level of sensitivity to Cdo RNAi in activation of the Gli-dependent reporter ( Figure 4H ).
Regions of Cdo Required for Myogenesis
Are Dispensible for Shh Signaling Cdo contains 5 Ig plus 3 fibronectin type III (FNIII) repeats in its ectodomain and a 270 amino acid cytoplasmic tail that does not resemble other proteins, and it promotes myogenesis as a part of complexes with additional Ig receptors and cadherins (Kang et al., , 2003 . A rat Cdo deletion mutant that lacks the first FNIII repeat (DFN1) is selectively deficient in its ability to bind cadherins and functions as a dominant-negative factor in myogenesis assays (Kang et al., 2003) . In contrast, the DFN1 mutant is as effective as full-length Cdo in enhancing ShhN-dependent reporter activity and in rescuing the effect of Cdo RNAi (Figures 4I and 4K ). Cdo's cytoplasmic tail is also required for its promyogenic function (Kang et al., 1998) , but a rat Cdo construct in which the intracellular region is replaced with GFP (DICR1) was also effective at stimulating ShhN-dependent transcription ( Figures 4J and 4K) . The structural determinants of Cdo's actions in myogenesis and Shh signaling are therefore distinct, suggesting that Cdo has multiple, independent functions.
Boc is the vertebrate protein most closely related to Cdo, and they can bind directly to one another in a cis fashion; although there may be some redundancy in their function, studies in myoblasts suggest they can work together . To address whether Boc also regulates Shh signaling, RNAi to Boc was tested for its effects on the Gli-dependent reporter in 10T1/2 cells. As seen for Cdo, cotransfection of a Boc RNAi expression vector that effectively reduced Boc protein levels diminished reporter activity in response to ShhN or transfected Gli1, though the degree of inhibition was somewhat less than that seen with Cdo RNAi (Figures 4L-4N) . A similar effect of Boc RNAi was seen with NIH3T3 cells ( Figure S1 ). Therefore, knockdown of either Cdo or Boc reduced Shh pathway activity, and it is possible that they may cooperate in regulation of Shh signaling.
Discussion
Mice that Lack Cdo: A Genetic Model of Human HPE Cdo 2/2 mice of a 129/Sv background show facial microforms of HPE with incomplete penetrance, while those of a C57BL/6 background display semilobar HPE and cebocephaly with >80% penetrance; limb development is grossly normal in both strains. Cdo-deficient mice therefore provide a genetic model of HPE that mimics the major unexplained features of human HPE, i.e., the wide phenotypic spectrum of forebrain and midface defects, with minimal involvement of other Shh-dependent structures. Furthermore, Cdo is intimately linked to the Shh pathway, defects in which are the most frequent known cause of human HPE . Together with the accompanying paper (Tenzen et al., 2006) , it is shown that Cdo functions to positively regulate Shh signaling in vivo and in vitro, likely by multiple mechanisms.
Taken together, the results suggest that Cdo positively regulates Shh signaling in and/or from the PCP in patterning the midline of the ventral forebrain and midface. The dependence of Shh signaling on Cdo in development of these latter structures is intriguing, in that this process is particularly sensitive to pathway signaling strength (Hu and Helms, 1999) and that coexpression of Cdo and Shh is restricted to the PCP (and notochord). Cdo may therefore function to regulate Shh signaling in a region of the embryo in which very high pathway activity is needed and the consequent developmental outcomes are dosage sensitive. Consistent with this possibility, Cdo is not essential for Shh signaling in general, even in C57BL/6 mice, as most Shh-dependent body structures develop normally in Cdo 2/2 animals. The lack of a limb phenotype in holoprosencephalic Cdo 2/2 mice is noteworthy. Cdo is unable to regulate Shh signaling in the posterior aspect of the developing limb because its expression is restricted to more anterior regions via high Shh activity itself in the posterior (Mulieri et al., 2000; Tenzen et al., 2006) . Additionally, a role for Cdo in patterning the limb at the fringes of the Shh gradient may be masked in Cdo 2/2 animals by potential redundancy with the closely related factor Boc, whose expression in the limb is virtually identical to that of Cdo; however, in contrast to Cdo, Boc is not expressed in the PCP or notochord Tenzen et al., 2006) . These observations provide a likely explanation of the selective Shh-like phenotype of Cdo 2/2 mice and a conceptual rationale for the similar phenotype of human HPE patients. It should be noted, however, that RNAi to either Cdo or Boc inhibited Shh signaling in vitro, and additional work will be required to identify potentially redundant versus cooperative functions of Cdo and Boc.
The modifier loci involved in the distinct phenotypic consequences of loss of Cdo in the 129/Sv or C57BL/6 strains are not known, but the C57BL/6 background also sensitizes mice lacking the BMP pathway regulator, Tsg, to HPE (and other phenotypes) (Petryk et al., 2004) . It is highly likely that genetic variation analogous to that found in different inbred strains of mice is widespread in the human population and might be sufficient to account for differences in penetrance and expressivity of HPE phenotypes of individuals carrying predisposing mutations, such as Shh haploinsufficiency. Severe HPE phenotypes could also be conferred on Cdo 2/2 mice of the less sensitive genetic background by removal of one copy of Shh (Tenzen et al., 2006) . Therefore, human CDO could function as both a bona fide HPE gene and a modifier of HPE genes.
Regulation of Shh Signaling by Cdo
RNAi to Cdo blocks Shh signaling in cultured fibroblasts, and it seems likely that Cdo enhances Hh pathway activity by multiple mechanisms, including (1) direct binding of Shh ligand (Tenzen et al., 2006) and (2) signaling by a parallel mechanism that regulates the Hh pathway at the level of Gli transcription factors or regulators of Gli factors. This second mechanism is consistent with the observation that Cdo does not stimulate a Gli-dependent reporter in the absence of ''classical'' pathway activators (Shh itself, or transfected SmoA1, Gli1, or Gli2) , but is important for reporter activity induced by each. It is possible that the need for Cdo at the level of Gli factors is related to Cdo's function as a coreceptor for other signaling ligands, such as netrins . In this regard, recent reports indicate that the Shh pathway may require ''basal'' levels of activity of other signaling pathways not directly stimulated by Shh signaling itself. For example, the ERK and PI-3 kinase/Akt pathways are required for several transcriptional and biological responses to Shh and Gli1 in vitro (Kessaris et al., 2004; Riobo et al., 2006a Riobo et al., , 2006b . Cdo may regulate signaling via one or more of these pathways in fibroblasts to gate Gli activity at a downstream point. The molecular mechanism by which Cdo signaling modulates Gli activity is not clear, but studies with Gli1, Gli2, and mutants of these factors indicate that it is not via alterations in protein stability, relief of a Gli transcriptional repression domain, or stimulation of a Gli trans-activation domain. Cdo may regulate Gli DNA binding activity or interaction with an unidentified cofactor.
Cdo may therefore stimulate Shh signaling by more than one mechanism, by binding to Shh at the cell surface, perhaps as part of the Hh receptor complex, and also by regulating parallel pathways that influence the activity of Hh-responsive transcription factors. These mechanisms are non-mutually exclusive. Again, however, neither of these Cdo functions is essential in vivo. Cdo is not expressed in such Shh-dependent structures as the most posterior aspect of the limb bud and the ventral neural tube (floor plate being an exception), nor is Boc. In these tissues, other Hh binding proteins may substitute for the former function. For the latter function, the required parallel pathway(s), if as generic as MAP and PI-3 kinases, are likely to be activated in vivo in more than one way. The strong dependence of cultured fibroblast lines on Cdo may reflect their particular dependence on this factor to provide such signaling function. It will be important in the future to identify the relative contributions in vivo of these distinct mechanisms for both Cdo and Boc and whether there is any higher order crossregulation that ties the mechanisms together.
Experimental Procedures
Mice Cdo +/lacZ-1 and Cdo +/lacZ-2 mice of a mixed 129/Sv 3 C57BL/6 background have been described (Cole and Krauss, 2003) . The phenotypes of mice homozygous for each mutation are similar except that the Cdo lacZ-2 allele expresses lacZ in a pattern that mimics endogenous Cdo expression, while the Cdo lacZ-1 allele expresses lacZ extremely weakly. Each Cdo allele was placed directly onto the 129/Sv background by crossing chimeric males produced by injection of targeted ES cells into blastocysts with 129/Sv females. To produce congenic Cdo +/2 C57BL/6 animals, males of the mixed background were backcrossed with C57BL/6 females for ten generations. Genotyping was by PCR with Cdo allele-specific primers. The two Cdo alleles were used interchangeably, except that Cdo lacZ-2 mice were used to monitor Cdo expression in Figure 2A and Cdo lacZ-1 mice were crossed with Ptch1 +/tm1Mps mice (Goodrich et al., 1997 ) so as to monitor Ptch1 lacZ reporter activity. Mice and embryos were processed for RNA in situ hybridization, b-gal staining, and hematoxylin and eosin staining as previously described (Cole and Krauss, 2003; Cole et al., 2004) . More detailed information on procedures with mice is available in the Supplemental Data.
Cells and Reporter Assays 10T1/2, NIH3T3, and 293T cells were cultured and transiently transfected as described . ShhN (Roelink et al., 1995) was produced by transfection of 293T cells and collection of conditioned medium (CM) 6 days later. For initial reporter assays, a range of CM dilutions were tested; Figure S2 shows that Cdo RNAi blocked reporter activity over a 100-fold dilution range. For the reporter assays shown in Figures 3 and 4 , the CM was diluted 100-fold with DMEM plus 2% FBS; this dilution gave a maximal response (Figure S2) . Reporter assays were generally performed as follows: cells were inoculated on 6-well plates and 24 hr later transfected with a total of 1 mg DNA, including reporter and indicated expression vectors, plus a Renilla luciferase vector as an internal control. The following day, cells were passaged into 24-well plates at 50% confluence and 24 hr later, where indicated, transferred to control or ShhN-containing CM. Luciferase assays were performed 48 hr later; data are reported as relative light units (luciferase activity/Renilla activity). To assess RNAi-mediated knockdown, a GFP expression vector was cotransfected with Cdo or Boc RNAi vectors, cells were sorted for the presence of GFP, and GFP + and GFP 2 populations were analyzed by Western blotting. For semiquantitative RT-PCR analysis of endogenous Ptch1, Gli, and Gapdh, cells were transfected as for assessment of RNAi efficacy and sorted for GFP expression; total RNA was isolated from GFP + cells and amplified as described (Gao et al., 2005) . More detailed information on the procedures described in this section is available in the Supplemental Data.
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